Roles of lipid mediators in early pregnancy events
Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Abstract
Background
Early pregnancy events, including embryo implantation, are critical for maintaining a healthy pregnancy and facilitating childbirth. Despite numerous signaling pathways implicated in establishing early pregnancy, a comprehensive understanding of implantation remains elusive.
Methods
This paper provides a comprehensive review of the current research on lipids in the context of early pregnancy, with a particular focus on feto‐maternal communications.
Main Findings
Embryo implantation entails direct interaction between uterine tissues and embryos. Introducing embryos triggers significant changes in uterine epithelial morphology and stromal differentiation, facilitating embryo implantation through communication with uterine tissue. Studies employing genetic models and chemical compounds targeting enzymes and receptors have elucidated the crucial roles of lipid mediators—prostaglandins, lysophosphatidic acid, sphingosine‐1‐phosphate, and cannabinoids—in early pregnancy events.
Conclusion
Given the high conservation of lipid synthases and receptors across species, lipid mediators likely play pivotal roles in rodents and humans. Further investigations into lipids hold promise for developing novel diagnostic and therapeutic approaches for infertility in humans.
Untitled section
Keywords: embryo implantation, lipids, mice, pregnancy, uterus
Article notes
Untitled section
Received 2024 Apr 22; Accepted 2024 Jun 24; Collection date 2024 Jan-Dec.
1.INTRODUCTION
Infertility is associated with social and health problems experienced by approximately 15% of couples worldwide. 1 Decades after the first childbirth by in vitro fertilization‐embryo transfer (IVF‐ET) was reported, the demand for artificial reproductive technologies (ARTs) has been increasing, especially in developed countries. However, 10–15% of couples undergoing IVF‐ETs suffer recurrent failures in implantation, and women fail to get pregnant at least three times, even using good‐quality embryos, 2 which indicates the crucial role of feto‐maternal circumstances in accepting and nourishing healthy embryos; however, the underlying mechanisms remain unclear owing to ethical and technical limitations associated with investigation of early pregnancy events in vivo.
Embryo implantation is a process in which the embryo and receptive endometrium interact intimately. 3 , 4 , 5 , 6 Rodents have been utilized to investigate the mechanisms underlying embryo implantation because of the similarity in female hormonal regulation and the responses of the endometrium to blastocysts between rodents and humans. 3 Gene deletions or chemical treatments in mouse models have revealed the mechanisms underlying the communication between uterine cells and embryos. 3 , 6 In this review, we describe previous reports of early pregnancy events focusing on the uterine functions of lipid mediators.
2.PROCESSES OF EMBRYO IMPLANTATION
Peri‐implantation embryos mainly comprise cells of fetal and placental origins. Implantation‐competent embryos, blastocysts, contain inner cell mass (ICM) that develops to the fetal body and is surrounded by trophoblasts that invade the endometrium to form the placenta. 7 The uterus, where embryos develop, comprises several types of cells: the endometria contain luminal/glandular epithelial cells and fibroblastic stromal cells. 3 Endothelial and immune cells in the endometria are considered to have both protective 8 , 9 and detrimental effects 10 , 11 during pregnancy. The myometrium surrounds the endometria and contributes to uterine contraction. 12 , 13 , 14 After fertilization, blastocysts enter the uterine cavity for spacing and apposition. 3 In mice, this event occurs between the morning and afternoon of day 4 (day 1 = plug‐positive day), corresponding to embryonic day 3.5 (E3.5) and E3.8. Subsequently, embryos attach to luminal cells at midnight on day 4. In humans and rodents, the luminal cells facing the embryos detach from the basal layers and are eliminated, 15 , 16 , 17 , 18 which promotes invasion of the trophoblast into the stromal area and placentation. Stromal cells around the attached embryos undergo cell differentiation (decidualization), 19 and key steps of this process have been well elucidated in rodents. 16 , 17 , 18 , 20 , 21 In the mouse uterus, stromal cells near the attached blastocysts differentiate into epithelial‐like cells from day 5 afternoon onward, forming a tight barrier to protect embryos from maternal immune cells and pathogens present in the circulation. 20 , 21 , 22 This multi‐layered epithelium‐like structure is called the primary decidual zone (PDZ), 20 , 23 which disappears by day 8. Stromal cells outside the PDZ differentiate into polyploid cells (forming secondary decidual zone, SDZ), which support embryonic growth via increased transcriptions. 24 , 25 , 26 On day 8, the cells in the SDZ reach terminal differentiation 27 and are shed with the placenta after delivery (Figure 1).
3.LIPID MEDIATORS IN EARLY PREGNANT UTERUS
Considering the adequate advances in rodent‐based research and the similarity of murine and human systems, 3 , 28 we focused on the studies in rodent models to demonstrate the uterine functions of bioactive lipids (lipid mediators) during early pregnancy. Lipids comprise a major component of the human body. Cells use lipids, such as triacylglycerols, for energy storage, 29 and phospholipids and steroids, to form cellular and organellar membranes. 30 Lipids also serve as a permeability barrier in the skin to protect against infections and inflammations. 31 Furthermore, accumulating evidence has revealed bioactivities of lipids. 32 Bioactive lipids, known as “lipid mediators,” are locally synthesized in response to extracellular stimuli, activating specific G protein‐coupled receptors in an autocrine or paracrine manner. 32 Here, we summarize the uterine functions of lipid mediators revealed by recent advances in mass spectroscopy, genome editing, and chemical treatments targeting synthesizing enzymes and receptors.
3.1.Prostaglandins
Prostaglandins (PGs) are lipid mediators synthesized from arachidonic acid (AA) by cyclooxygenases (COXs: COX‐1 and COX‐2) serving as rate‐limiting enzymes. 33 , 34 Each PG performs various cellular functions through specific G protein‐coupled receptors (GPCRs) 34 , 35 (Figure 2).
Phospholipase A2 (PLA2) influences the production of AA by cleaving the sn‐2 fatty acid chain of phospholipids. 33 Four kinds of PLA2s are reported in mammals: cytosolic (cPLA2), secretory (sPLA2), Ca2 + −independent (iPLA2), and platelet‐activating factor (PAF) hydrolase. In the mouse uterus, cPLA2 is crucial for early pregnancy events. 36 cPLA2α, a cPLA2 isoform, is highly expressed in the epithelial layer and stroma on days 4 and 5 of pregnancy, respectively, which coincides with Cox‐1 and Cox‐2 expression. Deletion of this enzyme causes delayed implantation and embryo crowding, accompanied by lowered PG levels. These abnormalities in embryo implantation cause defective fetoplacental development, hemorrhage, shared placentae, and fewer pups. 36 , 37 Treatment with PGE2 and cPGI (a PGI2 analog) can rescue the deferred implantation but not the embryo spacing in cPLA 2 α knockout (KO) females, 36 which indicates a potential involvement of other PG species in spacing.
In Cox‐2 KO females, severe infertility is associated with multiple anomalies in processes ranging from ovulation to parturition. 34 , 38 Although previous reports demonstrate the significant correlation of PG receptors with ovulation, fertilization, and parturition, 39 , 40 , 41 the receptor playing key roles in peri‐implantation processes remains unidentified. During early pregnancy in mice, several PG receptors have been detected in different types of cells in the uterus. 42 , 43 However, no single knockout of any prostaglandin receptor has been reported to disrupt uterine functions during early pregnancy. This suggests that multiple PG receptors may act concurrently in the uterus. A pharmacological analysis revealed that PGI2 plays a critical role in embryo implantation via activating a nuclear receptor PPARδ rather than GPCRs. 44 PPARδ is highly induced in stroma and decidua from day 4 evening onward. Additionally, treatments of PGI2 analog or PPARδ agonist improved the implantation rate in Cox‐2 KO females after embryo transfer; however, decidual tissue weights were smaller than the control one.
A recent transcriptome‐wide comparative study indicated the importance of COX‐2 in early pregnancy in marsupial to eutherian mammals. 45 , 46 In eutherian mammals, pro‐inflammatory gene expression is induced upon embryo attachement, while anti‐inflammatory signals are upregulated after implantation. 45 Contrastingly, marsupials have no anti‐inflammatory phase and exhibit a shorter pregnancy period. COX‐2 upregulation after attachment is highly conserved among these species. Furthermore, PGE2 treatment induces decidualization in stromal cells derived from pregnant opossums. 46 These results indicate that the COX‐2‐PGs pathways are evolutionarily conserved and are crucial in pregnancy events.
Although the role of intrauterine COX‐1 expression in early pregnancy remains unclear, it is highly expressed in the mouse uterine luminal epithelia on day 4. 36 Cox‐1 KO mice exhibit normal pregnancies except for defective parturition because of the compensatory induction of Cox‐2 expression in the early pregnant uterus. 13 However, Cox‐2 inhibition alone cannot induce noticeable abnormalities in the implantation which were observed in cPLA 2 α or Cox‐2 KO, 47 reflecting the potential role of Cox‐1 in early pregnancy. Moreover, Cox‐1 expression in the SDZ on days 7 and 8 suggests that Cox‐1 was involved in decidual reactions. 36 Li et al. demonstrated the possible roles of Cox‐1 during early pregnancy by utilizing mice with one‐by‐one substitution of Cox‐1 and Cox‐2 loci with knock‐in alleles reciprocally, which exhibited reduced fertility and defective embryo implantation. 48
As cPLA 2 α KO showed a normal decidual reaction, the PLA2 molecule responsible for decidualization has not been identified. 36 Studies in mice have shown that multiple PLA2 enzymes are expressed within the uterus during pregnancy, 36 suggesting cooperative roles in uterine function. Further research using pharmacological tools or conditional knockout systems could help address the remaining gaps in our understanding of the PLA2‐COXs‐PGs pathways within the pregnant uterus.
Furthermore, COX‐PGs are critical not only for uterine health but also for uterine pathology. In the uterine‐specific KO (uKO) mice with p53 KO, decidual senescence caused spontaneous preterm birth, which was associated with the upregulation of Cox‐2 and PGF2α, which can enhance myometrial contractility. 27 The preterm birth phenotype in p53 uKO was suppressed by a selective inhibitor of Cox‐2. Excessive Cox‐2 induction has also been observed in a preeclampsia‐like mouse model (BPH5). 49 In BPH5 mice, decidual Cox‐2 levels increased on day 6; however, the attachment reaction downregulated Cox‐2 levels compared to control mice. The upregulation of Cox‐2 disrupts the accumulation of decidual natural killer (NK) cells, which are critical for blood vessel remodeling at the feto‐maternal interface. Similar to preterm birth model mice, a Cox‐2 selective inhibitor repressed pathological conditions in BPH5, indicating the significance of properly regulated Cox‐2 and PG levels.
3.2.Lysophosphatidic acid (LPA)
Lysophosphatidic acid (LPA) is one of the simplest glycerophospholipids with a fatty acid chain and a phosphate group in the polar head. 32 , 50 , 51 LPA evokes various cellular processes, including cell proliferation, prevention of apoptosis, and cell migration, through activating six G‐protein‐coupled receptors (LPAR1‐6). LPA is mainly produced by a membrane‐binding enzyme called phosphatidic acid‐specific phospholipase A1α (PA‐PLA1α) 52 and a secreted enzyme called autotaxin (ATX) that exhibits lysophospholipase D activity 53 , 54 (Figure 3). Among the six LPA receptors, Lpar3 was reported to crucially influence early pregnancy events. 55 , 56 , 57 , 58 , 59 In mice, the expression of Lpar3 peaks on day 4 of pregnancy in a female sex hormone‐dependent manner. 55 , 56 It is expressed only in the luminal epithelial layer, directly interacting with the embryo. 55 Deletion of Lpar3 in female mice induces deferred embryo implantation and abnormal embryo spacing, resulting in reduced litter sizes and shared placenta 55 , 57 , 59 ; these outcomes are comparable to those observed in cPLA 2 α KO dams. 36 , 37
We previously reported that a Lpar3 agonist activates luminal Lpar3, contributing to decidual reactions. 59 Intrauterine injection of T13, a specific and potent agonist of Lpar3, 60 on day 4 caused robust decidual reactions throughout the uterine horns, which was induced by the sequential upregulation of early pregnancy event‐associated genes, 59 such as HB‐EGF and Cox‐2 expressed in the epithelia, 19 , 25 , 38 , 61 , 62 and Bmp2 and Wnt4 expressed in the stroma. 19 , 63 , 64
In contrast to this Lpar3 agonist‐induced decidualization throughout the uterine horns, 59 physiological decidualization occurs locally around attached embryos. 19 , 25 This outcome reflected that LPA synthesis and the subsequent activation of Lpar3 immediately in the vicinity of the embryos. Female mice missing PA‐PLA1α, an LPA‐synthetic enzyme, are fertile, which indicates no significant association of PA‐PLA1α with pregnancy processes. 65 Contrastingly, previous reports demonstrate potential roles for ATX in female reproduction. 53 , 66 , 67 However, the actual contribution of ATX to pregnancy is unclear because systemic deletion of ATX results in embryonic lethality, 68 making it difficult to study ATX functions in adults. Previously, 59 we demonstrated the localization of ATX in the apical surface of the luminal epithelium and detected lysophosphatidylcholine (LPC), a major substrate for ATX, in blastocysts. 54 , 69 Furthermore, pharmacological inhibition of ATX causes defective embryo implantation similar to that in Lpar3 KO mice. 59 These results suggest the importance of the ATX‐LPA‐Lpar3 axis at the blastocyst–epithelial boundary in inducing decidualization during early pregnancy.
All six LPA receptors were detected in the uteri of pregnant mice and primary cultured uterine stroma. 58 , 70 However, only Lpar3 was identified critical for early pregnancy in vivo. 55 , 56 , 57 , 59 Lpar1 is the most abundant LPA receptor in the uterus; however, neither single KO nor double KO of Lpar1 and Lpar2 receptors affect embryo implantation processes. 58 However, in our in vitro culture model of primary uterine stromal cells, inhibition of the ATX – Lpar1/3 axis dramatically suppressed cell proliferation. 70 These results suggest that Lpar1 plays a critical role in uterine cell growth. In human endometrial stromal cells cultured in vitro, LPA treatment induces IL‐8 expression via p38 MAP kinase and NF‐κB pathways. 71 Conditioned media derived from LPA‐treated stromal cells stimulate the migration of endothelial cells in vitro, indicating a possible role for LPAR1 in uterine angiogenesis.
Similar to cPLA 2 α KO, 36 Lpar3 KO mice exhibit flawed embryo spacing 55 , 57 ; however, the underlying mechanism remains unclear. Histological analyses revealed embryo spacing occurring from morning to evening on day 4 in the wild‐type (WT) uteri, whereas it is compromised in Lpar3 KO mice. 57 In an organ bath culture assay, T13 treatment caused uterine muscle contractions, which is potentially associated with uterine spacing. 57 Lpar3 is localized in luminal cells; some secretory molecules may act downstream of Lpar3 and cause uterine contractions. Nonetheless, activation of the PGE2/PGI2 axis, which is downregulated in Lpar3 KO uteri, only recovers the timing of attachment of the embryo, but not embryo spacing. 55 Moreover, comparable outcomes are recorded in cPLA 2 α KO, 36 suggesting that other PG species might contribute to embryo spacing.
Most LPA receptors are highly expressed throughout the body and are critical for fetal development, 50 , 51 making it difficult to validate the specific roles of LPA receptors expressed in pregnant uteri. Uterine‐specific KO mice and specific agonists/antagonists of each LPA receptor can facilitate further investigations.
3.3.Sphingolipids
Sphingosine‐1‐phosphate (S1P), a lysophospholipid with a phosphate head and sphingosine backbone, 72 , 73 is mainly produced in the cytoplasm by two sphingosine kinases (SPHK1 and SPHK2) via the phosphorylation of sphingosine. S1P lyase or S1Pase mediates intracellular degradation of S1P in the ER membrane and contributes to glycerophospholipid or ceramide synthesis. After extracellular release mediated by a specific transporter SPNS2, S1P functions as a lipid mediator through activation of GPCRs (S1pr1–5) (Figure 4).
Previous reports demonstrate the function of SphKs in decidualization. 74 , 75 , 76 Despite normal ovulation, fertilization, and embryo attachment in SphK1 −/−/SphK2 +/− females, they are completely infertile 74 . Further detailed analyses revealed the correlation between decidualization failure and their infertility. 75 SphK1 −/−/SphK2 +/− uteri exhibit reduced proliferation/differentiation and increased death of the stromal cells. These stromal defects cause poor decidualization, allowing neutrophil infiltration into the feto‐maternal interface, which causes tissue injury through the excessive neutrophil extracellular traps (NETs) formation. 75 , 76 NETs are neutrophil‐derived DNA/protein fibers that kill pathogens in the extracellular regions. 76 Pharmacological inhibition of chemoattractant signaling and NET formation partially rescues abortion in mutant mice. 76 Therefore, sphingolipids significantly impact decidualization and maintenance of pregnancy.
Mizukishi et al. also focused on exploring which sphingolipid molecule is critical for decidualization downstream of SphKs. In SphK1 −/−/SphK2 +/− uteri, the S1P level remains unaltered despite a lack of SphK activity, 74 whereas other sphingolipids, including sphingosine, are dramatically increased with reduced levels of phosphatidylethanolamine; these results suggest that the total balance of lipid compositions may influence decidual reactions. This notion was validated by a report that demonstrated highly expressed serine palmitoyltransferases (SPT; Sptlc1‐3), the first key enzymes for de novo sphingolipid synthesis, in the decidua and impairs decidualization induced by inhibition of SPT. 77
While it is still unclear whether S1P has any rolles in early pregnancy, Ye et al. reported that all S1P receptors are highly expressed in pregnant uteri. 58 Moreover, females with a single KO of S1pr2 and double KO of S1pr2/S1pr3 showed reduced litter sizes 78 ; however, the number of embryo implantation sites was comparable to that of WT on day 5 immediately after embryo attachment. 58 Hence, we propose that S1P signaling plays an important role in post‐implantation events, including decidualization.
3.4.Cannabinoids
Cannabinoids comprise a class of lipids that exert psychoactive effects by activating two GPCRs: CNR1 and CNR2. 79 , 80 In early pregnant mice, Cnr1 is found in trophoblasts and broadly throughout the endometria. 81 , 82 , 83 The expression of Cnr2 is evident in the inner cell mass of blastocysts, blood cells, and endothelial cells; however, it is not detected in uterine cells. 81 , 84 , 85 In the 1990s, endogenous ligands for CNR1/CNR2 (endocannabinoids) were identified. 86 , 87 Among endocannabinoids, anandamide (arachidonoylethanolamide; AEA) and 2‐arachidonoylglycerol (2‐AG) have been well explored. AEA is produced by N‐acyl phosphoethanolamine phospholipase D (NAPE‐PLD) activity and degraded by fatty acid amide hydrolase to generate AA and ethanolamine (FAAH). 79 , 88 Contrastingly, 2‐AG is produced by sn1‐diacylglycerol lipase (DAGL) and is degraded mainly by monoacylglycerol lipase (MAGL) to form AA and glycerol. 79 , 89 In early pregnant mice, NAPE‐PLD and DAGLα are highly expressed in the epithelial layers (Figure 5). 90 , 91
Previous genetic and pharmacological analyses have revealed the vital roles of cannabinoids in the murine female reproductive system of mice. 82 , 84 , 85 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 Both upregulation and suppression of cannabinoid signaling via Cnr1 were reported to compromise proper embryonic development. A single deletion of Cnr1 can cause a 50% reduction in pregnancy rate. 84 Double deletion of Cnr1 and Cnr2 further reduces female fertility, leading to an 80% reduction in pregnancy rates. FAAH is found in the uterine stroma of humans as well as mice, and Faah KO females exhibit increased levels of anandamide and reduced fertility. 94 These findings indicate that the strictly regulated cannabinoid signaling significantly impacts pregnancy.
Here, we have focused on the functions of cannabinoids at the feto‐maternal interface during early pregnancy, although cannabinoid pathways are also involved in oviductal transport 84 and protection from preterm birth. 95 , 98 Recently, Cnr1/Cnr2 has been reported as important factors regulating PDZ formation. 85 In the uteri of females with Cnr1/Cnr2 double KO (DKO), poorly formed PDZ causes excessive infiltration of macrophages near the attached blastocysts. Hif2α, a critical transcriptional factor expressed in PDZ to promote trophoblast invasion, 17 is downregulated in the PDZ of Cnr1/Cnr2 DKO. 83 Moreover, embryo invasion is compromised in the mutant uteri, which facilitates abortion. Trophoblastic cells are crucial for embryonic invasion and subsequent placentation. 97 Trophoblastic stem cells derived from Cnr1 KO exhibit decreased invasive activity compared to the WT control group. 82 , 96 , 97 In addition, the trophoblast‐specific deletion of Cnr1 leads to defects in placentation and reduced birth rates; however, these anomalies are less severe than those found in the systemic deletion of Cnr1. 82
Marijuana, which contains the cannabinoid Δ9‐tetrahydrocannabinol (Δ9‐THC), is clinically used to alleviate morning sickness. However, in Western countries, it is commonly abused by pregnant women. 99 Moreover, circulating AEA levels are correlated with increased abortion rates in pregnant women. 100 The roles uncovered in mouse studies may hold promise for the future treatment of these human pathologies.
4.CONCLUSIONS
In conclusion, appropriate communication between the embryo and endometria is crucial for successful pregnancy and childbirth, which is evidently governed by lipid mediators (Figure 6, Table 1). This review summarizes accumulating evidence demonstrating the significance of lipid mediators in establishing and maintaining early pregnancy. As lipid synthases and receptors are highly conserved across species, 33 , 50 , 73 , 79 the lipids, exhibiting significant impact in mouse models, are considered to play pivotal roles in other mammals, including humans. The possible involvement of bioactive lipids in the maintenance of pregnancy in humans was reported. 66 , 100 LPA synthesis was detected in follicular fluids collected from IVF patients. 66 Another study found that patients with higher levels of circulating anandamide tend to experience failed pregnancies after IVF‐ET. 100 However, as these human studies have been occurred on IVF patients, the role of bioactive lipids in pregnancy in healthy subjects remains unclear. One reason for the limitation in human research is the ethical difficulty of collecting pregnant human uterine tissues. In addition, it is difficult to accurately estimate pregnancy stages in humans, especially during the peri‐implantation period, without dissecting specimens of pregnant uteri. 101 However, recently, in vitro models of human implantation and embryogenesis have been actively tested, 102 , 103 , 104 , 105 which may contribute to future lipid research in human feto‐maternal interfaces.
| Enzymes involved in lipid synthesis and their expression sites in uteri during pregnancy | Functional downstream receptors in uteri during pregnancy and their expression sites | Function in uteri during early pregnancy | References | |
|---|---|---|---|---|
| PGs | COX‐1/luminal epithelia before the attachment COX‐2/luminal epithelia and stroma in the vicinity of the attached embryos | Unknown PPARδ?/decidua | Embryo spacing Timed embryo implantation Decidualization | 27, 34, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 |
| LPA | ATX/luminal epithelia | LPAR3/luminal epithelia during the receptive phase | Embryo spacing Timed embryo implantation Decidualization | 50, 51, 55, 56, 57, 58, 59, 65, 66, 67, 68, 70, 71 |
| Sphingolipids | SPHK1 and SPHK2 /decidua | S1PR2 and S1PR3?/decidua | Decidualization | 58, 74, 75, 76, 77, 78 |
| Cannabinoids | NAPE‐PLD for AEA and DAGLα for 2‐AG/luminal epithelia | CNB1/trophectoderm and PDZ CNB2/ICM and endothelia | Decidualization Embryo invasion | 80, 81, 82, 83, 84, 85, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100 |
Despite the progress in lipid research focusing on uterine functions, several questions remain unanswered. In previous studies, researchers have primarily utilized systemic KO mice for each lipid‐related gene. This makes it difficult to determine whether the phenotypes result solely from uterine dysfunctions or if other organs are also involved. Uterine‐specific gene deletion using Cre‐loxP systems such as Pgr‐Cre 106 or Ltf‐iCre 107 could be used to clarify the distinct roles of lipid mediators in the uterus. While the roles of SPHK1/2 and cannabinoids have been studied in‐depth, it remains unclear how LPA and PGs influence uterine functions. Establishment of uterine‐specific KO for each LPA/PGs receptor will clarify their uterine roles. As they have common downstream G‐proteins, it is possible that LPA/PGs receptors share certain functions. 108 Therefore, multiple KO of LPA/PGs receptors might be required in future studies.
While the crucial roles of lipids have been identified, the spatiotemporally regulated functional mechanism of each lipid molecule remains unclear due to technical limitations. These include ethical barriers to investigating human pregnancy and difficulties in detecting lipid mediators in situ. Recently, spatial transcriptomes and lipidomes have been rapidly developed, and novel roles of lipids have been unveiled. Further studies on lipids can contribute to developing new methods for diagnosing and treating infertility in humans.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
ACKNOWLEDGMENTS
This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (grant Nos. JP22H02538, JP22H03222, JP22K19595, JP22K19596, and JP23H02483), Japan Agency for Medical Research and Development (AMED) (grant Nos. 23gn0110069, JP23gn0110056, JP23gk0210028, JP23lk0310083, and JP23lk0201158), Children and Families Agency Program (grant No. JPMH23DB0101), Japan Science and Technology Agency (JST) Fusion Oriented Research for disruptive Science and Technology (FOREST) (grant No. JPMJFR210H), Astellas Foundation for Research on Metabolic Disorders, and the fund of joint research with NIPRO Corporation.
Untitled section
Aikawa S, Hirota Y. Roles of lipid mediators in early pregnancy events. Reprod Med Biol. 2024;23:e12597. 10.1002/rmb2.12597
REFERENCES
Untitled section
References
- 1. Cox CM, Thoma ME, Tchangalova N, Mburu G, Bornstein MJ, Johnson CL, et al. Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta‐analysis. Hum Reprod Open. 2022;2022(4):hoac051.
- 2. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014;28(1):14–38.
- 3. Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med. 2012;18(12):1754–1767.
- 4. Fukui Y, Hirota Y, Matsuo M, Gebril M, Akaeda S, Hiraoka T, et al. Uterine receptivity, embryo attachment, and embryo invasion: multistep processes in embryo implantation. Reprod Med Biol. 2019;18(3):234–240.
- 5. Hirota Y. Progesterone governs endometrial proliferation‐differentiation switching and blastocyst implantation. Endocr J. 2019;66(3):199–206.
- 6. Maurya VK, DeMayo FJ, Lydon JP. Illuminating the "black box" of progesterone‐dependent embryo implantation using engineered mice. Front Cell Dev Biol. 2021;9:640907.
- 7. Maltepe E, Bakardjiev AI, Fisher SJ. The placenta: transcriptional, epigenetic, and physiological integration during development. J Clin Invest. 2010;120(4):1016–1025.
- 8. Fu B, Zhou Y, Ni X, Tong X, Xu X, Dong Z, et al. Natural killer cells promote fetal development through the secretion of growth‐promoting factors. Immunity. 2017;47(6):1100–1113.
- 9. Ono Y, Yoshino O, Hiraoka T, Sato E, Fukui Y, Ushijima A, et al. CD206+ M2‐like macrophages are essential for successful implantation. Front Immunol. 2020;11:557184.
- 10. Deng W, Yuan J, Cha J, Sun X, Bartos A, Yagita H, et al. Endothelial cells in the decidual bed are potential therapeutic targets for preterm birth prevention. Cell Rep. 2019;27(6):1755–1768.
- 11. Aikawa S, Deng W, Liang X, Yuan J, Bartos A, Sun X, et al. Uterine deficiency of high‐mobility group box‐1 (HMGB1) protein causes implantation defects and adverse pregnancy outcomes. Cell Death Differ. 2019;27:1489–1504.
- 12. Gross GA, Imamura T, Luedke C, Vogt SK, Olson LM, Nelson DM, et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc Natl Acad Sci U S A. 1998;95(20):11875–11879.
- 13. Reese J, Brown N, Paria BC, Morrow J, Dey SK. COX‐2 compensation in the uterus of COX‐1 deficient mice during the pre‐implantation period. Mol Cell Endocrinol. 1999;150(1–2):23–31.
- 14. Ueda Y, Kimura‐Yoshida C, Mochida K, Tsume M, Kameo Y, Adachi T, et al. Intrauterine pressures adjusted by Reichert's membrane are crucial for early mouse morphogenesis. Cell Rep. 2020;31(7):107637.
- 15. Enders AC. Trophoblast differentiation during the transition from trophoblastic plate to lacunar stage of implantation in the rhesus monkey and human. Am J Anat. 1989;186(1):85–98.
- 16. Li Y, Sun X, Dey SK. Entosis allows timely elimination of the luminal epithelial barrier for embryo implantation. Cell Rep. 2015;11(3):358–365.
- 17. Matsumoto L, Hirota Y, Saito‐Fujita T, Takeda N, Tanaka T, Hiraoka T, et al. HIF2α in the uterine stroma permits embryo invasion and luminal epithelium detachment. J Clin Invest. 2018;128(7):3186–3197.
- 18. Akaeda S, Hirota Y, Fukui Y, Aikawa S, Shimizu‐Hirota R, Kaku T, et al. Retinoblastoma protein promotes uterine epithelial cell cycle arrest and necroptosis for embryo invasion. EMBO Rep. 2021;22(2):e50927.
- 19. Paria BC, Ma W, Tan J, Raja S, Das SK, Dey SK, et al. Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci U S A. 2001;98(3):1047–1052.
- 20. Paria BC, Zhao X, Das SK, Dey SK, Yoshinaga K. Zonula occludens‐1 and E‐cadherin are coordinately expressed in the mouse uterus with the initiation of implantation and decidualization. Dev Biol. 1999;208(2):488–501.
- 21. Yuan J, Aikawa S, Deng W, Bartos A, Walz G, Grahammer F, et al. Primary decidual zone formation requires scribble for pregnancy success in mice. Nat Commun. 2019;10(1):5425.
- 22. Tachi C, Tachi S. Macrophages and implantation. Ann N Y Acad Sci. 1986;476:158–182.
- 23. Krehbiel RH. Cytological studies of the decidual reaction in the rat during early pregnancy and in the production of Deciduomata. Physiol Zool. 1937;10(2):212–234.
- 24. Das SK. Cell cycle regulatory control for uterine stromal cell decidualization in implantation. Reproduction. 2009;137(6):889–899.
- 25. Tan Y, Li M, Cox S, Davis MK, Tawfik O, Paria BC, et al. HB‐EGF directs stromal cell polyploidy and decidualization via cyclin D3 during implantation. Dev Biol. 2004;265(1):181–195.
- 26. Das SK, Lim H, Paria BC, Dey SK. Cyclin D3 in the mouse uterus is associated with the decidualization process during early pregnancy. J Mol Endocrinol. 1999;22(1):91–101.
- 27. Hirota Y, Daikoku T, Tranguch S, Xie HR, Bradshaw HB, Dey SK. Uterine‐specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. J Clin Investig. 2010;120(3):803–815.
- 28. Wang H, Dey SK. Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet. 2006;7(3):185–199.
- 29. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006;312(5774):734–737.
- 30. Murakami M. Lipoquality control by phospholipase a(2) enzymes. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(9):677–702.
- 31. Yamamoto K, Miki Y, Sato M, Taketomi Y, Nishito Y, Taya C, et al. The role of group IIF‐secreted phospholipase A2 in epidermal homeostasis and hyperplasia. J Exp Med. 2015;212(11):1901–1919.
- 32. Shimizu T. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol. 2009;49:123–150.
- 33. Murakami M, Kudo I. Recent advances in molecular biology and physiology of the prostaglandin E2‐biosynthetic pathway. Prog Lipid Res. 2004;43(1):3–35.
- 34. Sugimoto Y, Inazumi T, Tsuchiya S. Roles of prostaglandin receptors in female reproduction. J Biochem. 2015;157(2):73–80.
- 35. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79(4):1193–1226.
- 36. Song H, Lim H, Paria BC, Matsumoto H, Swift LL, Morrow J, et al. Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for ‘on‐time’ embryo implantation that directs subsequent development. Development. 2002;129(12):2879–2889.
- 37. Uozumi N, Kume K, Nagase T, Nakatani N, Ishii S, Tashiro F, et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature. 1997;390(6660):618–622.
- 38. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, et al. Multiple female reproductive failures in cyclooxygenase 2‐deficient mice. Cell. 1997;91(2):197–208.
- 39. Tamba S, Yodoi R, Segi‐Nishida E, Ichikawa A, Narumiya S, Sugimoto Y. Timely interaction between prostaglandin and chemokine signaling is a prerequisite for successful fertilization. Proc Natl Acad Sci U S A. 2008;105(38):14539–14544.
- 40. Hizaki H, Segi E, Sugimoto Y, Hirose M, Saji T, Ushikubi F, et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci U S A. 1999;96(18):10501–10506.
- 41. Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science. 1997;277(5326):681–683.
- 42. Yang ZM, Das SK, Wang J, Sugimoto Y, Ichikawa A, Dey SK. Potential sites of prostaglandin actions in the periimplantation mouse uterus: differential expression and regulation of prostaglandin receptor genes. Biol Reprod. 1997;56(2):368–379.
- 43. Lim H, Dey SK. Prostaglandin E2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation. Endocrinology. 1997;138(11):4599–4606.
- 44. Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, et al. Cyclo‐oxygenase‐2‐derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev. 1999;13(12):1561–1574.
- 45. Griffith OW, Chavan AR, Protopapas S, Maziarz J, Romero R, Wagner GP. Embryo implantation evolved from an ancestral inflammatory attachment reaction. Proc Natl Acad Sci U S A. 2017;114(32):E6566–E6575.
- 46. Erkenbrack EM, Maziarz JD, Griffith OW, Liang C, Chavan AR, Nnamani MC, et al. The mammalian decidual cell evolved from a cellular stress response. PLoS Biol. 2018;16(8):e2005594.
- 47. Reese J, Zhao X, Ma WG, Brown N, Maziasz TJ, Dey SK. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase‐1 and cyclooxygenase‐2 function in female reproduction in mice. Endocrinology. 2001;142(7):3198–3206.
- 48. Li X, Ballantyne LL, Crawford MC, FitzGerald GA, Funk CD. Isoform‐specific compensation of cyclooxygenase (Ptgs) genes during implantation and late‐stage pregnancy. Sci Rep. 2018;8(1):12097.
- 49. Sones JL, Cha J, Woods AK, Bartos A, Heyward CY, Lob HE, et al. Decidual Cox2 inhibition improves fetal and maternal outcomes in a preeclampsia‐like mouse model. JCI Insight. 2016;1(3):e75351.
- 50. Yung YC, Stoddard NC, Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res. 2014;55(7):1192–1214.
- 51. Aikawa S, Hashimoto T, Kano K, Aoki J. Lysophosphatidic acid as a lipid mediator with multiple biological actions. J Biochem. 2015;157(2):81–89.
- 52. Sonoda H, Aoki J, Hiramatsu T, Ishida M, Bandoh K, Nagai Y, et al. A novel phosphatidic acid‐selective phospholipase A1 that produces lysophosphatidic acid. J Biol Chem. 2002;277(37):34254–34263.
- 53. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid‐producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem. 2002;277(42):39436–39442.
- 54. Umezu‐Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol. 2002;158(2):227–233.
- 55. Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, et al. LPA3‐mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature. 2005;435(7038):104–108.
- 56. Hama K, Aoki J, Bandoh K, Inoue A, Endo T, Amano T, et al. Lysophosphatidic receptor, LPA3, is positively and negatively regulated by progesterone and estrogen in the mouse uterus. Life Sci. 2006;79(18):1736–1740.
- 57. Hama K, Aoki J, Inoue A, Endo T, Amano T, Motoki R, et al. Embryo spacing and implantation timing are differentially regulated by LPA3‐mediated lysophosphatidic acid signaling in mice. Biol Reprod. 2007;77(6):954–959.
- 58. Ye X, Herr DR, Diao H, Rivera R, Chun J. Unique uterine localization and regulation may differentiate LPA3 from other lysophospholipid receptors for its role in embryo implantation. Fertil Steril. 2011;95(6):2107–2113.
- 59. Aikawa S, Kano K, Inoue A, Wang J, Saigusa D, Nagamatsu T, et al. Autotaxin‐lysophosphatidic acid‐LPA3 signaling at the embryo‐epithelial boundary controls decidualization pathways. EMBO J. 2017;36(14):2146–2160.
- 60. Tamaruya Y, Suzuki M, Kamura G, Kanai M, Hama K, Shimizu K, et al. Identifying specific conformations by using a carbohydrate scaffold: discovery of subtype‐selective LPA‐receptor agonists and an antagonist. Angew Chem Int Ed Engl. 2004;43(21):2834–2837.
- 61. Xie H, Wang H, Tranguch S, Iwamoto R, Mekada E, Demayo FJ, et al. Maternal heparin‐binding‐EGF deficiency limits pregnancy success in mice. Proc Natl Acad Sci U S A. 2007;104(46):18315–18320.
- 62. Kim YS, Yuan J, Dewar A, Borg JP, Threadgill DW, Sun X, et al. An unanticipated discourse of HB‐EGF with VANGL2 signaling during embryo implantation. Proc Natl Acad Sci U S A. 2023;120(20):e2302937120.
- 63. Lee KY, Jeong JW, Wang JR, Ma LJ, Martin JF, Tsai SY, et al. Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol. 2007;27(15):5468–5478.
- 64. Franco HL, Dai D, Lee KY, Rubel CA, Roop D, Boerboom D, et al. WNT4 is a key regulator of normal postnatal uterine development and progesterone signaling during embryo implantation and decidualization in the mouse. FASEB J. 2011;25(4):1176–1187.
- 65. Inoue A, Arima N, Ishiguro J, Prestwich GD, Arai H, Aoki J. LPA‐producing enzyme PA‐PLA(1)alpha regulates hair follicle development by modulating EGFR signalling. EMBO J. 2011;30(20):4248–4260.
- 66. Tokumura A, Miyake M, Nishioka Y, Yamano S, Aono T, Fukuzawa K. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients. Biol Reprod. 1999;61(1):195–199.
- 67. Yamamoto J, Omura M, Tuchiya K, Hidaka M, Kuwahara A, Irahara M, et al. Preferable existence of polyunsaturated lysophosphatidic acids in human follicular fluid from patients programmed with in vitro fertilization. Prostaglandins Other Lipid Mediat. 2016;126:16–23.
- 68. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, et al. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem. 2006;281(35):25822–25830.
- 69. Nishimasu H, Okudaira S, Hama K, Mihara E, Dohmae N, Inoue A, et al. Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat Struct Mol Biol. 2011;18(2):205–212.
- 70. Aikawa S, Kano K, Inoue A, Aoki J. Proliferation of mouse endometrial stromal cells in culture is highly sensitive to lysophosphatidic acid signaling. Biochem Biophys Res Commun. 2017;484(1):202–208.
- 71. Chen SU, Lee H, Chang DY, Chou CH, Chang CY, Chao KH, et al. Lysophosphatidic acid mediates interleukin‐8 expression in human endometrial stromal cells through its receptor and nuclear factor‐kappaB‐dependent pathway: a possible role in angiogenesis of endometrium and placenta. Endocrinology. 2008;149(11):5888–5896.
- 72. Proia RL, Hla T. Emerging biology of sphingosine‐1‐phosphate: its role in pathogenesis and therapy. J Clin Invest. 2015;125(4):1379–1387.
- 73. Sanchez T, Hla T. Structural and functional characteristics of S1P receptors. J Cell Biochem. 2004;92(5):913–922.
- 74. Mizugishi K, Li C, Olivera A, Bielawski J, Bielawska A, Deng CX, et al. Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. J Clin Invest. 2007;117(10):2993–3006.
- 75. Mizugishi K, Inoue T, Hatayama H, Bielawski J, Pierce JS, Sato Y, et al. Sphingolipid pathway regulates innate immune responses at the fetomaternal interface during pregnancy. J Biol Chem. 2015;290(4):2053–2068.
- 76. Mizugishi K, Yamashita K. Neutrophil extracellular traps are critical for pregnancy loss in sphingosine kinase‐deficient mice on 129Sv/C57BL/6 background. FASEB J. 2017;31(12):5577–5591.
- 77. Ding NZ, Qi QR, Gu XW, Zuo RJ, Liu J, Yang ZM. De novo synthesis of sphingolipids is essential for decidualization in mice. Theriogenology. 2018;106:227–236.
- 78. Ishii I, Ye X, Friedman B, Kawamura S, Contos JJ, Kingsbury MA, et al. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1‐phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG‐5 and S1P(3)/LP(B3)/EDG‐3. J Biol Chem. 2002;277(28):25152–25159.
- 79. Ahn K, McKinney MK, Cravatt BF. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev. 2008;108(5):1687–1707.
- 80. Sun X, Dey SK. Endocannabinoid signaling in female reproduction. ACS Chem Nerosci. 2012;3(5):349–355.
- 81. Das SK, Paria BC, Chakraborty I, Dey SK. Cannabinoid ligand‐receptor signaling in the mouse uterus. Proc Natl Acad Sci U S A. 1995;92(10):4332–4336.
- 82. Kim YS, Li Y, Yuan J, Borg JP, Sun X, Dey SK. Cannabinoid and planar cell polarity signaling converges to direct placentation. Proc Natl Acad Sci U S A. 2021;118(38):e2108201118.
- 83. Li YJ, Dewar A, Kim YS, Dey SK, Sun XF. Pregnancy success in mice requires appropriate cannabinoid receptor signaling for primary decidua formation. Elife. 2020;9:e61762.
- 84. Wang H, Guo Y, Wang D, Kingsley PJ, Marnett LJ, Das SK, et al. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004;10(10):1074–1080.
- 85. Li Y, Bian F, Sun X, Dey SK. Mice missing Cnr1 and Cnr2 show implantation defects. Endocrinology. 2019;160(4):938–946.
- 86. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–1949.
- 87. Mechoulam R, Ben‐Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, et al. Identification of an endogenous 2‐monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995;50(1):83–90.
- 88. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty‐acid amides. Nature. 1996;384(6604):83–87.
- 89. Moriyama T, Urade R, Kito M. Purification and characterization of diacylglycerol lipase from human platelets. J Biochem. 1999;125(6):1077–1085.
- 90. Wang H, Xie H, Sun X, Kingsley PJ, Marnett LJ, Cravatt BF, et al. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins Other Lipid Mediat. 2007;83(1–2):62–74.
- 91. Guo Y, Wang H, Okamoto Y, Ueda N, Kingsley PJ, Marnett LJ, et al. N‐acylphosphatidylethanolamine‐hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem. 2005;280(25):23429–23432.
- 92. Paria BC, Song H, Wang X, Schmid PC, Krebsbach RJ, Schmid HH, et al. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem. 2001;276(23):20523–20528.
- 93. Paria BC, Wang H, Dey SK. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. Chem Phys Lipids. 2002;121(1–2):201–210.
- 94. Wang H, Xie H, Guo Y, Zhang H, Takahashi T, Kingsley PJ, et al. Fatty acid amide hydrolase deficiency limits early pregnancy events. J Clin Invest. 2006;116(8):2122–2131.
- 95. Wang H, Xie H, Dey SK. Loss of cannabinoid receptor CB1 induces preterm birth. PLoS One. 2008;3(10):e3320.
- 96. Sun X, Xie H, Yang J, Wang H, Bradshaw HB, Dey SK. Endocannabinoid signaling directs differentiation of trophoblast cell lineages and placentation. Proc Natl Acad Sci U S A. 2010;107(39):16887–16892.
- 97. Xie H, Sun X, Piao Y, Jegga AG, Handwerger S, Ko MS, et al. Silencing or amplification of endocannabinoid signaling in blastocysts via CB1 compromises trophoblast cell migration. J Biol Chem. 2012;287(38):32288–32297.
- 98. Sun X, Cappelletti M, Li Y, Karp CL, Divanovic S, Dey SK. Cnr2 deficiency confers resistance to inflammation‐induced preterm birth in mice. Endocrinology. 2014;155(10):4006–4014.
- 99. UNODCO . United nations office on drugs and crime. World Drug Report 2017.
- 100. Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna C, et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod. 2002;8(2):188–195.
- 101. Enders AC. Trophoblast‐uterine interactions in the first days of implantation: models for the study of implantation events in the human. Semin Reprod Med. 2000;18(3):255–263.
- 102. Weatherbee BAT, Gantner CW, Iwamoto‐Stohl LK, Daza RM, Hamazaki N, Shendure J, et al. Pluripotent stem cell‐derived model of the post‐implantation human embryo. Nature. 2023;622(7983):584–593.
- 103. Oldak B, Wildschutz E, Bondarenko V, Comar MY, Zhao C, Aguilera‐Castrejon A, et al. Complete human day 14 post‐implantation embryo models from naive ES cells. Nature. 2023;622(7983):562–573.
- 104. Kagawa H, Javali A, Khoei HH, Sommer TM, Sestini G, Novatchkova M, et al. Human blastoids model blastocyst development and implantation. Nature. 2022;601(7894):600–605.
- 105. Shibata S, Endo S, Nagai LAE, Kobayashi EH, Oike A, Kobayashi N, et al. Modeling embryo‐endometrial interface recapitulating human embryo implantation. Sci Adv. 2024;10(8):eadi4819.
- 106. Soyal SM, Mukherjee A, Lee KY, Li J, Li H, DeMayo FJ, et al. Cre‐mediated recombination in cell lineages that express the progesterone receptor. Genesis. 2005;41(2):58–66.
- 107. Daikoku T, Ogawa Y, Terakawa J, Ogawa A, DeFalco T, Dey SK. Lactoferrin‐iCre: a new mouse line to study uterine epithelial gene function. Endocrinology. 2014;155(7):2718–2724.
- 108. Inoue A, Raimondi F, Kadji FMN, Singh G, Kishi T, Uwamizu A, et al. Illuminating G‐protein‐coupling selectivity of GPCRs. Cell. 2019;177(7):1933–1947.